BALY vs TSLA

BALY exhibits severe financial distress with a Piotroski F-Score of just 2/9, indicating weak fundamental health. The company is unprofitable with a negative ROE of -115.63%, a deeply negative forward P/E of -8.25, and a profit margin of -17.41%, signaling ongoing earnings deterioration. Despite a low Price/Sales ratio of 0.33 suggesting possible value, extreme leverage (Debt/Equity: 10.85) and poor earnings predictability—evidenced by an average earnings surprise of -149.99% over the last four quarters—undermine any valuation appeal. Technical trend and insider sentiment are neutral to bearish, reinforcing a high-risk profile.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.